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Other names: DKFZp434O192; MGC138683 
Location: 15q14 (position 32425358-32437221 on the 
chromosome 15 genomic sequence). 
Note: the gene name NUT has not been approved by 
the HUGO Gene Nomenclature Committee. 
DNA/RNA 
Description 
The gene consists of 7 exons that span approximately 
12 kb of genomic DNA in the centromere-to-telomere 
orientation. The translation initiation codon and the 
stop codon are predicted to exon 1 and exon 7, 
respectively. 
Transcription 




The open reading frame is predicted to encode an 1127
amino acid protein with an estimated molecular weight 
of 120 kDa. 
Expression 
Northern blot analysis has indicated that the normal 
expression of the NUT gene is highly restricted to the







Carcinoma with t(15;19)(q14;p13) 
translocation 
Prognosis 
Carcinoma with t(15;19) translocation is invariably 
fatal with a rapid clinical course when located to the 
midline thoracic, head and neck structures. One tumor, 
displaying the cytogenetic and molecular cytogenetic 
features of carcinoma with t(15;19) translocation, but
located to the iliac bone has been reported successfully 
cured. 
It has been suggested that a critical prognostic 
difference exists between BRD4-NUT/t(15;19) positive 
tumors and tumors where NUT is rearranged but fused 
to an as yet unknown partner. 
Cytogenetics 
t(15;19)(q14;p13) [reported breakpoints: t(15;19)(q11-
15;p13)]. 
Hybrid/Mutated Gene 
The t(15;19)(q14;p13) results in an BRD4-NUT 
chimeric gene where exon 10 of BRD4 is fused to exon 
2 of NUT. 
Abnormal Protein 
The BRD4-NUT fusion is composed of the N-terminal 
of BRD4 (amino acids 1-720 out of 1372) and almost 
the entire protein sequence of NUT (amino acids 6-
1127). The N-terminal of BRD4 includes 
bromodomains 1 and 2 and other, less well 
characterized functional domains. 
Oncogenesis 
It has been suggested that the oncogenic effect of the 
NUT-BRD4 fusion is caused not only by the abnormal 
regulation of NUT by BRD4 promoter elements but 
also by the consequent ectopic expression of NUT in 
non-germinal tissues. 
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Breakpoints 
Note: The vast majority of reported breakpoints in 
carcinoma with t(15;19) translocation were assigned to 
band 19p13, the exception being the cytogenetic 
interpretation of a 19q13 breakpoint reported once. The 
reported breakpoints on chromosome 15 have varied 
(15q11-q15). 
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